Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: PRIME THERAPEUTICS, PRIME THERAPEUTICS
Client-Reported Lobbying Expenses
$8.6M
183 filings
Firm Income Reported for This Client
$2.5M
Not substituted for client expenses
Summary
PRIME THERAPEUTICS is an organization, based in MN. Its political footprint includes $8.6 million in client-reported lobbying expenses, $2.5 million in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Medicare/Medicaid, Pharmacy, Alcohol and Drug Abuse. Political activity spans from 2008 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 85% YoY
2025: $720K (complete years)
118 individual donors listing this company as employer
Activity data: Senate LDA